{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 75,
        "end": 82
      }
    },
    {
      "id": "T2",
      "obj": "Disease",
      "span": {
        "begin": 91,
        "end": 101
      }
    },
    {
      "id": "T3",
      "obj": "Disease",
      "span": {
        "begin": 104,
        "end": 111
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 203,
        "end": 224
      }
    },
    {
      "id": "T7",
      "obj": "Disease",
      "span": {
        "begin": 249,
        "end": 259
      }
    },
    {
      "id": "T8",
      "obj": "Disease",
      "span": {
        "begin": 264,
        "end": 281
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "20101393_3",
  "text": "OBJECTIVES : The current study aimed to determine the relationship between ecstasy use and depressive / anxiety symptomatology after controlling for known environmental and genetic ( polymorphism of the serotonin transporter gene ) risk factors for depression and anxiety disorders ."
}
